Company: SXTPW
Filing Date: 2025-08-15
Form Type: PRE 14A
Source: 0001213900-25-077435
Chunk: 43

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-15
Form: PRE 14A
Chunk 43
---
 of our common stock that may be subject to awards under the 2022 Plan was equal to 3,977. The 2022 Plan provides for
an annual automatic increase in the number of shares available for issuance beginning on January 1, 2023, and each January 1 thereafter,
by four percent (4%) of the number of outstanding shares of common stock on the immediately preceding December 31, or such lesser number
of shares as determined by our Board. On July 16, 2024 and November 6, 2024, our stockholders approved an increase to the number of shares
available under the 2022 Plan by 83,334 shares and 100,000 shares, respectively, which increases were previously approved by the Board.
As of the Record Date, the maximum shares of our common stock that may be subject to awards under the 2022 Plan is equal to 215,452.

<div align='center'>24</div>

Plan Administration

One or more committees
appointed by our Board will administer the 2022 Plan. Initially, the Compensation Committee shall administer the 2022 Plan. In addition,
if we determine it is desirable to qualify transactions under the 2022 Plan as exempt under Rule 16b-3 of the Exchange Act, such transactions
will be structured with the intent that they satisfy the requirements for exemption under Rule 16b-3. Subject to the provisions of the
2022 Plan, the administrator has the power to administer the 2022 Plan and make all determinations deemed necessary or advisable for administering
the 2022 Plan, including the power to determine the fair market value of our common stock, select the service providers to whom awards
may be granted, determine the number of shares covered by each award, approve forms of award agreements for use under the 2022 Plan, determine
the terms and conditions of awards (including the exercise price, the time or times at which the awards may be exercised, any vesting
acceleration or waiver or forfeiture restrictions and any restriction or limitation regarding any award or the shares relating thereto),
construe and interpret the terms of the 2022 Plan and awards granted under it, prescribe, amend and rescind rules relating to the 2022
Plan, rules and regulations relating to sub-plans established for the purpose of facilitating compliance with applicable non-U.S. laws,
easing the administration of the 2022 Plan and/or for qualifying for favorable tax treatment under applicable non-U.S